GUCD1, also known as Guanylyl Cyclase Domain Containing 1, is a protein encoded by the GUCD1 gene. This protein belongs to the family of guanylyl cyclases, which are enzymes that catalyze the conversion of guanosine triphosphate (GTP) into cyclic guanosine monophosphate (cGMP). cGMP is a second messenger molecule that plays a critical role in various biological processes, including vasodilation, platelet aggregation, and phototransduction in the retina.Unlike soluble guanylyl cyclases that are typically activated by nitric oxide (NO), GUCD1 is part of the membrane-bound guanylyl cyclases, which are activated by different mechanisms, often involving the binding of specific ligands to their extracellular domain. However, the exact physiological activators and the detailed mechanisms of action for GUCD1 are not well characterized.
The presence of a guanylyl cyclase domain suggests that GUCD1 is involved in the production of cGMP within the cell. Through its enzymatic activity, it may play a role in cell signaling pathways that require cGMP as a signaling molecule. These pathways can influence various cellular functions, including smooth muscle relaxation, neuronal signaling, and fluid homeostasis.It is important to note that while GUCD1 shares homology with other guanylyl cyclases, the specific tissues in which it is expressed and the exact physiological contexts in which it operates may differ. The biological significance of GUCD1 remains an area for further exploration, with potential implications for understanding cGMP-related signaling pathways and their effects on cellular and physiological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Nitric oxide donors can stimulate guanylyl cyclase, potentially enhancing GUCD1 activity by increasing cGMP production. | ||||||
Tadalafil | 171596-29-5 | sc-208412 | 50 mg | $180.00 | 13 | |
Similar to Sildenafil, Tadalafil inhibits phosphodiesterase 5, potentially affecting GUCD1 activity through elevated cGMP levels. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil, another phosphodiesterase 5 inhibitor, may indirectly influence GUCD1 by increasing cGMP levels. | ||||||
Riociguat | 625115-55-1 | sc-476845 | 5 mg | $300.00 | ||
Riociguat, a stimulator of soluble guanylyl cyclase, could indirectly impact GUCD1 by enhancing cGMP production. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases cAMP levels, which can interact with cGMP pathways, potentially affecting GUCD1. | ||||||
Dipyridamole | 58-32-2 | sc-200717 sc-200717A | 1 g 5 g | $31.00 $102.00 | 1 | |
Dipyridamole inhibits phosphodiesterases and may increase cGMP levels, potentially impacting GUCD1. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
As a phosphodiesterase 3 inhibitor, Cilostazol can influence cAMP and cGMP levels, potentially affecting GUCD1. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Milrinone, another phosphodiesterase 3 inhibitor, may indirectly influence GUCD1 through its effects on cGMP. | ||||||
Amrinone | 60719-84-8 | sc-207288 | 1 g | $193.00 | ||
Similar to Milrinone, Amrinone affects cAMP and cGMP levels, potentially impacting GUCD1 activity. | ||||||